Literature DB >> 1829681

Atrial natriuretic peptide in patients with acute myocardial infarction without functional heart failure.

F M Gutierrez-Marcos1, A Fernandez-Cruz, J Gutkowska, C Herrero, A Blesa, V Estrada, C Loscos, J M López-Novoa.   

Abstract

The purpose of the present study was to measure plasma levels of atrial natriuretic peptide (ANP) in patients with acute myocardial infarction without heart failure, and also to assess the temporal sequence of changes of plasma ANP during the first hours of recovery from myocardial infarction. The study was performed in 22 patients who were admitted to the Intensive Care Unit with the diagnosis of acute myocardial ischaemia that had an evolution of less than 6 h. Blood samples were drawn on admission and at 1, 8, and 24 h, and plasma concentrations of ANP, renin, aldosterone, epinephrine, norepinephrine and vasopressin were measured. Compared with control subjects, on admission patients showed increased plasma levels of ANP, as well as increased plasma renin activity (PRA), aldosterone, norepinephrine, epinephrine, dopamine, and antidiuretic hormone (ADH). ANP, but not renin or aldosterone plasma values, decreased with time, and there was a significant correlation between ANP and time after onset of pain. No increase in plasma creatinine was observed during the hospital stay, and the patients showed a negative fluid balance. No relationship was found between the location or extension of the infarction, or morphine treatment and ANP plasma levels. The high levels of ANP seem to counteract the haemodynamic and fluid-retention effects of the vasoconstrictive factors released after myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1829681     DOI: 10.1093/oxfordjournals.eurheartj.a059930

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  5 in total

1.  Oxidation of CaMKII determines the cardiotoxic effects of aldosterone.

Authors:  B Julie He; Mei-Ling A Joiner; Madhu V Singh; Elizabeth D Luczak; Paari Dominic Swaminathan; Olha M Koval; William Kutschke; Chantal Allamargot; Jinying Yang; Xiaoqun Guan; Kathy Zimmerman; Isabella M Grumbach; Robert M Weiss; Douglas R Spitz; Curt D Sigmund; W Matthijs Blankesteijn; Stephane Heymans; Peter J Mohler; Mark E Anderson
Journal:  Nat Med       Date:  2011-11-13       Impact factor: 53.440

Review 2.  The emerging role of aldosterone/mineralocorticoid receptors in the pathogenesis of erectile dysfunction.

Authors:  Fei Wu; Yun Lin; Qingyong Liu
Journal:  Endocrine       Date:  2018-05-02       Impact factor: 3.633

Review 3.  CaMKII oxidative activation and the pathogenesis of cardiac disease.

Authors:  Elizabeth D Luczak; Mark E Anderson
Journal:  J Mol Cell Cardiol       Date:  2014-02-13       Impact factor: 5.000

4.  Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods.

Authors:  A M Choy; D Darbar; C C Lang; T H Pringle; G P McNeill; N S Kennedy; A D Struthers
Journal:  Br Heart J       Date:  1994-07

5.  Myocardial pathology induced by aldosterone is dependent on non-canonical activities of G protein-coupled receptor kinases.

Authors:  Alessandro Cannavo; Daniela Liccardo; Akito Eguchi; Katherine J Elliott; Christopher J Traynham; Jessica Ibetti; Satoru Eguchi; Dario Leosco; Nicola Ferrara; Giuseppe Rengo; Walter J Koch
Journal:  Nat Commun       Date:  2016-03-02       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.